Market Place
Sourcing Support
Tempus Collaborates with JW Pharmaceutical for R&D Insights
28 Oct 2024 //
BUSINESSWIRE
Oncocross, JW Pharma: AI-Driven Anticancer, Regenerative Drug Development
27 May 2024 //
BUSINESSWIRE
Oncocross expands collab with JW for AI-based oncology drug discovery in Korea
27 May 2024 //
BIOSPECTRUM ASIA
JW Pharma launches 1st pitavastatin-ezetimibe combo therapy for dyslipidemia
29 Sep 2021 //
KOREABIOMED
JW Pharmaceutical to repurpose targeted oncology drug as COVID-19 therapy
16 Jun 2020 //
KOREAHERALD
Simcere & JW Pharma Announce Collaboration for Anti-Gout Drug URC-102 in China
28 Sep 2019 //
BIOSPACE
Korean drugmaker buys large Vietnamese plant
05 Sep 2019 //
FIERCE PHARMA
LEO Pharma Files IND Application to FDA for a Clinical Study of JW1601/LP0190
26 Aug 2019 //
BUSINESSWIRE
JW Pharmaceutical signs global out-licensing agreement with LEO Pharma
24 Aug 2018 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.